Xuan Marian Thai

Array ( [id] => 122112 [patent_doc_number] => 07709611 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-04 [patent_title] => 'Antibodies to Dkk-1' [patent_app_type] => utility [patent_app_number] => 11/197665 [patent_app_country] => US [patent_app_date] => 2005-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 38897 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/709/07709611.pdf [firstpage_image] =>[orig_patent_app_number] => 11197665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 910634 [patent_doc_number] => 07329737 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-12 [patent_title] => 'Antibodies that bind hK-1' [patent_app_type] => utility [patent_app_number] => 11/196627 [patent_app_country] => US [patent_app_date] => 2005-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 54852 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/329/07329737.pdf [firstpage_image] =>[orig_patent_app_number] => 11196627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4791646 [patent_doc_number] => 20080292619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Pharmaceutical Composition Containing Meltrin Antagonist' [patent_app_type] => utility [patent_app_number] => 11/659194 [patent_app_country] => US [patent_app_date] => 2005-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 38778 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20080292619.pdf [firstpage_image] =>[orig_patent_app_number] => 11659194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5386532 [patent_doc_number] => 20090227777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'Monoclonal antibody for hippuric acid antigen' [patent_app_type] => utility [patent_app_number] => 11/989066 [patent_app_country] => US [patent_app_date] => 2005-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12336 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227777.pdf [firstpage_image] =>[orig_patent_app_number] => 11989066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5348822 [patent_doc_number] => 20090004183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'Compositions and Methods for Regulating the Alternative Pathway of Complement' [patent_app_type] => utility [patent_app_number] => 11/658124 [patent_app_country] => US [patent_app_date] => 2005-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 19507 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004183.pdf [firstpage_image] =>[orig_patent_app_number] => 11658124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5309736 [patent_doc_number] => 20090017017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'Anti-rhesus d recombinant polyclonal antibody and methods of manufacture' [patent_app_type] => utility [patent_app_number] => 11/632937 [patent_app_country] => US [patent_app_date] => 2005-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 29013 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20090017017.pdf [firstpage_image] =>[orig_patent_app_number] => 11632937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5125504 [patent_doc_number] => 20070237775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'Anti-Ghrelin Antibodies' [patent_app_type] => utility [patent_app_number] => 11/569769 [patent_app_country] => US [patent_app_date] => 2005-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20241 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20070237775.pdf [firstpage_image] =>[orig_patent_app_number] => 11569769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7702633 [patent_doc_number] => 08088386 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-03 [patent_title] => 'Treatment of complement-associated disorders' [patent_app_type] => utility [patent_app_number] => 11/159919 [patent_app_country] => US [patent_app_date] => 2005-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 71 [patent_no_of_words] => 45568 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/088/08088386.pdf [firstpage_image] =>[orig_patent_app_number] => 11159919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5894382 [patent_doc_number] => 20060002921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Optimized dosing with anti-CD4 antibodies for tolerance induction in primates' [patent_app_type] => utility [patent_app_number] => 11/158505 [patent_app_country] => US [patent_app_date] => 2005-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 21378 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20060002921.pdf [firstpage_image] =>[orig_patent_app_number] => 11158505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5813923 [patent_doc_number] => 20060084086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Proteins, polynucleotides encoding them and methods of using the same' [patent_app_type] => utility [patent_app_number] => 11/156300 [patent_app_country] => US [patent_app_date] => 2005-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73573 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084086.pdf [firstpage_image] =>[orig_patent_app_number] => 11156300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4824986 [patent_doc_number] => 20080124343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Treatment of Inappropriate Immune Responses' [patent_app_type] => utility [patent_app_number] => 11/629934 [patent_app_country] => US [patent_app_date] => 2005-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12432 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124343.pdf [firstpage_image] =>[orig_patent_app_number] => 11629934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5799308 [patent_doc_number] => 20060034841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Method of depleting regulatory T cell' [patent_app_type] => utility [patent_app_number] => 11/144731 [patent_app_country] => US [patent_app_date] => 2005-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17852 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20060034841.pdf [firstpage_image] =>[orig_patent_app_number] => 11144731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5342302 [patent_doc_number] => 20090180952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'Ligands binding the complex of urokinase-type plasminogen activator (uppa) and its receptor (upar) that inhibit downstream upar interactions: identification and use in diagnosis or therapy' [patent_app_type] => utility [patent_app_number] => 11/597689 [patent_app_country] => US [patent_app_date] => 2005-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 24431 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20090180952.pdf [firstpage_image] =>[orig_patent_app_number] => 11597689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4439853 [patent_doc_number] => 07927592 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-19 [patent_title] => 'Method of inhibiting complement activation' [patent_app_type] => utility [patent_app_number] => 10/908738 [patent_app_country] => US [patent_app_date] => 2005-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4966 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/927/07927592.pdf [firstpage_image] =>[orig_patent_app_number] => 10908738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5336736 [patent_doc_number] => 20090053200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Method for retarding unhealth manifestations brought by ageing of human beings' [patent_app_type] => utility [patent_app_number] => 11/919141 [patent_app_country] => US [patent_app_date] => 2005-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3771 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053200.pdf [firstpage_image] =>[orig_patent_app_number] => 11919141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4932488 [patent_doc_number] => 20080003263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-03 [patent_title] => 'Anti-Gluten Egg Yolk Antibodies for the Treatment of Celiac Disease' [patent_app_type] => utility [patent_app_number] => 10/599660 [patent_app_country] => US [patent_app_date] => 2005-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4639 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20080003263.pdf [firstpage_image] =>[orig_patent_app_number] => 10599660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4634035 [patent_doc_number] => 08012483 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-06 [patent_title] => 'Phosphorylcholine conjugates and corresponding antibodies' [patent_app_type] => utility [patent_app_number] => 10/599934 [patent_app_country] => US [patent_app_date] => 2005-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8814 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/012/08012483.pdf [firstpage_image] =>[orig_patent_app_number] => 10599934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4669344 [patent_doc_number] => 20080044404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Annexin V for Preventing Atherothrombosis and Plaque Rupture' [patent_app_type] => utility [patent_app_number] => 10/599937 [patent_app_country] => US [patent_app_date] => 2005-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5282 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20080044404.pdf [firstpage_image] =>[orig_patent_app_number] => 10599937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7051493 [patent_doc_number] => 20050187380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Method for treating Th2-mediated disease' [patent_app_type] => utility [patent_app_number] => 11/094718 [patent_app_country] => US [patent_app_date] => 2005-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 26541 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20050187380.pdf [firstpage_image] =>[orig_patent_app_number] => 11094718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7050729 [patent_doc_number] => 20050186616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Human cystatin F' [patent_app_type] => utility [patent_app_number] => 11/088093 [patent_app_country] => US [patent_app_date] => 2005-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23029 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20050186616.pdf [firstpage_image] =>[orig_patent_app_number] => 11088093 [rel_patent_id] =>[rel_patent_doc_number] =>)